Implementation of a hepatitis A/B vaccination program using an accelerated schedule among high-risk inmates, Los Angeles County Jail, 2007–2010

Costumbrado, John; Stirland, Ali; Cox, Garrett; El-Amin, Alvin Nelson; Miranda, Armidia; Carter, Ann; Malek, M. A.

doi:10.1016/j.vaccine.2012.09.006

Cited by 19 publications

(18 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The methods used to investigate the vaccination status of the inmates were: serological testing ( n = 10) [ 20 , 21 , 23 , 24 , 25 , 35 , 42 , 44 , 45 , 46 ], the use of questionnaires ( n = 5) [ 28 , 33 , 37 , 38 , 40 ], the combination of both ( n = 3) [ 26 , 31 , 36 ], the screening of institutional databases ( n = 5) [ 27 , 29 , 30 , 32 , 34 ], or directly by conducting a survey ( n = 5) [ 19 , 22 , 39 , 41 , 43 ].…”

Section: Resultsmentioning

confidence: 99%

“…The aim of the studies was to evaluate systematic vaccination or relevant update of the adult vaccination program ( n = 21) [ 19 , 21 , 22 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 ], to explore the coverage of risk groups ( n = 7) [ 20 , 23 , 36 , 42 , 43 , 44 , 45 ], including in some studies vaccination status at the time of admission to prison ( n = 6) [ 20 , 24 , 35 , 37 , 43 , 46 ]. The risk groups studied were IDUs and hepatitis C positive (HCV) in the HBV studies [ 23 , 42 , 43 , 44 , 45 ], and men who have sex with men in a combined HAV/HBV immunization study [ 19 ] and in another HAV immunization study [ 20 ]. In 11 studies (39.2%), exclusively men were included [ 19 , 21 , 25 , 29 , 34 , 35 , 36 , 37 , 39 , 41 , …”

Section: Resultsmentioning

confidence: 99%

“…The risk groups studied were IDUs and hepatitis C positive (HCV) in the HBV studies [ 23 , 42 , 43 , 44 , 45 ], and men who have sex with men in a combined HAV/HBV immunization study [ 19 ] and in another HAV immunization study [ 20 ]. In 11 studies (39.2%), exclusively men were included [ 19 , 21 , 25 , 29 , 34 , 35 , 36 , 37 , 39 , 41 , 42 ], in 4 studies (14.2%) only women were included [ 22 , 24 , 28 , 38 ], in 11 articles (39.2%) both sexes [ 23 , 26 , 27 , 30 , 31 , 32 , 33 , 43 , 44 , 45 , 46 ] and in 2 (7.1%) these data were not recorded [ 20 , 40 ]. The most studied vaccination coverage was HBV ( n = 21) [ 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 42 , …”

Section: Resultsmentioning

confidence: 99%

See 2 more Smart Citations

Vaccination Coverage among Prisoners: A Systematic Review

Vicente-Alcalde¹,

Ruescas-Escolano

Harboe

et al. 2020

IJERPH

View full text Add to dashboard Cite

Prison inmates are highly susceptible for several infectious diseases, including vaccine-preventable diseases. We conducted a systematic international literature review on vaccination coverage against hepatitis B virus (HBV), hepatitis A virus (HAV), combined HAV/HBV, tetanus-diphtheria, influenza, pneumococcal, and combined measles, mumps, and rubella (MMR) in prison inmates, according to the PRISMA guidelines. The electronic databases were used Web of Science, MEDLINE, Scopus, and Cinhal. No language or time limit were applied to the search. We defined vaccination coverage as the proportion of vaccinated prisoners. There were no limitations in the search strategy regarding time period or language. Of 1079 identified studies, 28 studies were included in the review. In total, 21 reported on HBV vaccine coverage (range between 16–82%); three on HAV (range between 91–96%); two studies on combined HAV/HBV (77% in the second dose and 58% in the third); three studies on influenza vaccine (range between 36–46%), one of pneumococcal vaccine coverage (12%), and one on MMR coverage (74%). We found that data on vaccination coverage in prison inmates are scarce, heterogeneous, and do not include all relevant vaccines for this group. Current published literature indicate that prison inmates are under-immunized, particularly against HBV, influenza, MMR, and pneumococci. Strengthen immunization programs specifically for this population at risk and improvement of data record systems may contribute to better health care in prisoners.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Vaccination Coverage among Prisoners: A Systematic Review

Vicente-Alcalde¹,

Ruescas-Escolano

Harboe

et al. 2020

IJERPH

View full text Add to dashboard Cite

show abstract

“…The introduction of HBV vaccine in countries with a high burden of HBV infection has significantly reduced the prevalence of this infection and related complications 27 . Several clinical trials have previously shown that an accelerated vaccination schedule increases the likelihood of inducing high ab response in highly HBV endemic areas and in individuals who are at risk of acquiring HBV infection, especially immuno-compromised patients 28 – 33 . In our prospective vaccination study, healthy controls and HIV-1 infected children received three doses of HBV vaccine and 96% of the children responded to this vaccine with an increased titer of anti-HBV vaccine abs at 1 month from the last vaccination dose.…”

Section: Discussionmentioning

confidence: 99%

T follicular helper cells and antibody response to Hepatitis B virus vaccine in HIV-1 infected children receiving ART

Bekele

Yibeltal

Bobosha

et al. 2017

Sci Rep

View full text Add to dashboard Cite

HBV vaccine has 95% efficacy in children to prevent HBV infection and related cancer. We conducted a prospective study in HIV-1 infected children receiving ART (n = 49) and controls (n = 63) to assess humoral and cellular responses to HBV vaccine provided with three doses under an accelerated schedule of 4 weeks apart. At 1 month post-vaccination all children, except 4 HIV-1 infected, displayed protective antibody (ab) titers to HBV vaccine; ab titers were lower in infected children (P < 0.0001). Ab titers decreased (P < 0.0001) in both HIV-1 infected and control children at 6 months. The frequency of circulating Tfh (cTFh) cells was 20.3% for controls and 20.8% for infected children prior to vaccination and remained comparable post-vaccination. Cytokine expression by cTfh cells upon activation with HBV antigen was comparable in the two groups at baseline and 1 month post-vaccination. Higher plasma levels (P < 0.0001) of CXCL13 were found in infected children which correlated with cTfh cell frequency at baseline. In conclusion, a lower ab response to HBV vaccine was measured in HIV-1 infected children. The frequency and activation profile of cTfh cells was comparable in infected children and controls suggesting that cells other than Tfh cells are responsible for impaired ab response to HBV vaccine.

show abstract

“…Routine HBV vaccination programmes implemented in prisons in Scotland, England, and Wales have been particularly successful in achieving vaccine coverage and uptake. 72,73 Results from one study 74 in the USA suggest that a combined hepatitis A and B vaccination programme, with an accelerated schedule among high-risk inmates, can be successfully implemented in a jail setting. These initiatives play an essential role in preventing chronic disease among members of a susceptible population.…”

Section: Figurementioning

confidence: 99%

Clinical care of incarcerated people with HIV, viral hepatitis, or tuberculosis

et al. 2016

View full text Add to dashboard Cite

The burden of HIV/AIDS and other transmissible diseases is higher in prison and jail settings than in the non-incarcerated communities that surround them. In this comprehensive review, we discuss available literature on the topic of clinical management of people infected with HIV, hepatitis B and C viruses, and tuberculosis in incarcerated settings in addition to co-occurrence of one or more of these infections. Methods such as screening practices and provision of treatment during detainment periods are reviewed to identify the effect of community-based treatment when returning inmates into the general population. Where data are available, we describe differences in the provision of medical care in the prison and jail settings of low-income and middle-income countries compared with high-income countries. Structural barriers impede the optimal delivery of clinical care for prisoners, and substance use, mental illness, and infectious disease further complicate the delivery of care. For prison health care to reach the standards of community-based health care, political will and financial investment are required from governmental, medical, and humanitarian organisations worldwide. In this review, we highlight challenges, gaps in knowledge, and priorities for future research to improve health-care in institutions for prisoners.

show abstract

Implementation of a hepatitis A/B vaccination program using an accelerated schedule among high-risk inmates, Los Angeles County Jail, 2007–2010

Cited by 19 publications

References 10 publications

Vaccination Coverage among Prisoners: A Systematic Review

Vaccination Coverage among Prisoners: A Systematic Review

T follicular helper cells and antibody response to Hepatitis B virus vaccine in HIV-1 infected children receiving ART

Clinical care of incarcerated people with HIV, viral hepatitis, or tuberculosis

Contact Info

Product

Resources

About